<DOC>
	<DOCNO>NCT01493102</DOCNO>
	<brief_summary>The purpose study evaluate incidence hypotension base discontinuation order norepinephrine vasopressin patient receive concomitant norepinephrine vasopressin infusion treatment septic shock .</brief_summary>
	<brief_title>Discontinuation Order Vasopressors Septic Shock</brief_title>
	<detailed_description>There little data regard discontinuation vasopressor patient septic shock . Therefore , investigator intend evaluate incidence hypotension base discontinuation order norepinephrine vasopressin patient receive concomitant norepinephrine vasopressin infusion treatment septic shock .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<mesh_term>Vasopressins</mesh_term>
	<mesh_term>Arginine Vasopressin</mesh_term>
	<mesh_term>Vasoconstrictor Agents</mesh_term>
	<criteria>patient 20 year age old patient receive concomitant therapy norepinephrine vasopressin teh management septic shock patient begin reduce vasopressor patient expire care withdrawn receive norepinephrine vasopressin patient transfer ICU outside facility operating room patient suspect vasopressin deficiency ( eg . HPA axis dysfunction , empty sella ) acute myocardial infarction Congestive heart failure ( NYHA functional classification III IV ) acute mesenteric ischemia patient receive vasopressor except norepinephrine vasopressin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>septic shock</keyword>
	<keyword>norepinephrine</keyword>
	<keyword>vasopressin</keyword>
	<keyword>hypotension</keyword>
</DOC>